Vizamyl
NDC 17156-067, Flutemetamol F-18, solution, from GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare).
- Product NDC
- 17156-067
- Status
- Listed
- Labeler
- GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare)
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA203137
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/17156-067 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FLUTEMETAMOL F-184.05 mCi/mL
Pharmacologic classes
Radioactive Diagnostic Agent [EPC]; Radiopharmaceutical Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 17156-067-30 | 17156006730 | 1 VIAL, MULTI-DOSE in 1 CONTAINER (17156-067-30) / 30 mL in 1 VIAL, MULTI-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/b3558f16-8f9a-4e55-8d9c-836427ebaa57
Use it
Look up 17156-067 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/17156-067 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 17156-067. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.